Browse > Article

Anti-cancer Effects of Bujeonghangam-tang on Human Neuroblastoma Cell Line LAN5  

Cho, Young-Kee (Wonkwang University Jeonju Oriental Medicine Hospital)
Lee, Seong-Kyun (Wonkwang University Jeonju Oriental Medicine Hospital)
Lee, Jung-Sup (Wonkwang University Jeonju Oriental Medicine Hospital)
Nam, Sang-Kyu (Wonkwang University Jeonju Oriental Medicine Hospital)
Jeong, Hyun-Ae (Wonkwang University Iksan Oriental Medicine Hospital)
Moon, Goo (Wonkwang University Jeonju Oriental Medicine Hospital)
Moon, Mi-Hyun (Wonkwang University Jeonju Oriental Medicine Hospital)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.20, no.6, 2006 , pp. 1548-1555 More about this Journal
Abstract
Bujeonghangam-tang(BHT) has been used as an anticancer agent in oriental medicine, but the mechanism by which it induces cell death in cancer cells is still unclear. To investigate cell death mechanism by BHT in cancer cells, the activities of apoptosis signaling pathway were tested in human neuroblastoma cell line LAN5. Viability of LAN5 cells was markedly decreased by treatment of the water extract of BHT in a dose-dependent manner. BHT induced cell death was confirmed as apoptosis characterized by chromatin condensation. We tested whether the water extract of BHT affects the anti-apoptotic protein such as Bcl-2 and Bcl-XL, and the pro-apoptotic protein such as Bax. Both Bcl-2 and Bcl-XL were gradually decreased but Bas was increased in a time-dependent manner after the addition of the water extract of BHT. Cleavage of Bid by activation of caspase-8 protease was also observed in LAN-5 cells by the treatment of the water extract of BHT. Taken together, these results suggest that the water extract of BHT exerts anti-cancer effects on human neuroblastoma LAN-5 cells by inducing the apoptotic death via down-regulation of anti-apoptotic proteins such as Bcl-2 and Bcl-XL, up-regulation of pro-apoptotic protein such as Bax, and activation of intrinsic caspase cascades.
Keywords
Bujeonghanggam-tang; human neuroblastoma cell line LAN5;
Citations & Related Records
연도 인용수 순위
  • Reference
1 崔昇勳. 東醫腫瘍學. 서울, 杏林出版社, pp 9, 19-100, 1995
2 Sasaki, S. Antitumor agents from medical plants, Jpn. Kokai Tokyo koho Jp, pp 58-118, 1983
3 Tang Defang, Hao Yohung, Liu Zuoya, Miao Shulin, Wei Hua, Wu Jian. Constituents of the essential oil from rhizome of Attactylodes macrocephala produced in pingjiang (China) and their antitumor effects, Yaoxue Tongbao, 19(9):555-558. 1984
4 노훈정. 消積補中丸의 抗腫瘍效果에 관한 實驗的 硏究. 익산, 원광대학교 대학원, 1995
5 신민교. 臨床本草學. 서울, 永林社, pp 172-173, 179-183, 188-191, 194-196, 211-212, 236-239, 255-260, 279-280, 469-472, 479-480, 480-481, 567-568, 569-570, 576-577, 585-588, 593-594, 668-669, 688-689, 819-821, 1997
6 林美良. 扶正抗癌湯이 抗腫瘍 면역반응에 미치는 영향. 익산, 원광대학교 대학원, 1997
7 崔云榮. 扶正抗癌湯이 抗癌작용 및 면역기능에 미치는 영향. 익산, 원광대학교 1999
8 Klaus, S.O., Davide, F. Apoptosis signal by death receptors, Eur. J. Biochem, 254:439-459. 1998   DOI   ScienceOn
9 Raff, M.C., Bares, B.A., Burne, J.F., Coles, H.S., Ishizaki, Y., Jacobson, M.D. Programed cell death and the control of cell survival. Science 262:695-700, 1993   DOI
10 Kim, C.N., Wang, X., Huang, A.M., Liu, I., Fang, G., Bhalla, K. Overexpression of Bcl-xL inhibits Ara-C-induced mitochondrial loss of cytochrome c and other pertubations that activate the molecular cascade of apoptosis. Cancer Res, 57:3115, 1997
11 Kluck, R.M., Martin, S.J., Hoffman, B.M., Zhou, J.S., Green, D.R., Newmeyer, D.D. Cytochrome c activation of CPP32-like proteplysis plays a critical role on a Xenopus cell-free apoptosis system, 1997
12 Widmann, C., Gibson, S. Caspase-dependent Cleavage of signaling proteins during apoptosis. J. Biol. Chem. 273(12):7141-7147, 1998   DOI   ScienceOn
13 Kharbanda, S. et al. Role for Bcl-xL as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis. Proc. Natl Acad. Sci, USA, 94:6939-6942, 1997
14 Thomson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462, 1995   DOI
15 王洪圖. 黃帝內經素問. 春秋出版社, p 71, 237, 271, 1988
16 Dai, J., Weinberg, S.R., Waxman, S., Jing, Y. Maligment cells can ge sensitixed to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glultathione redox system. Blood. 93:268-277. 1999
17 Shimizu S., Narita M., Tsujimoto Y. : Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC, Nature 399:411-412, 1999   DOI   ScienceOn
18 上海中醫學院. 中醫外科學. 香港, 商務印書館, pp 301-307, 239-164, 1994
19 Shigeomi S., Masashi N., Yoshihide T. : Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC, Nature 399:483-487, 1999   DOI   ScienceOn
20 Mesner, P., Budihardjo, I., Kaufmann, S.H. Chemotherapy- induced apoptosis. Adv. Pharmacol. 41:461, 1997.   DOI
21 Mattew, G., Vander Heiden, Navdeep, S.C., Edward, K.W., Paul, T.S. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria, 91:627-637, 1997   DOI   ScienceOn
22 Adams J.M., Cory S. : The Bcl-2 protein family: arbiters of cell survival, Science 281:1322-1326, 1998   DOI   ScienceOn
23 Desagher, S., Martinou, J.C. Mitochondria as the central control point of apoptosis, Trends Cell Biol, 10(9):369-377, 2000   DOI   ScienceOn
24 錢伯文. 腫瘤的辨證施治. 上海, 上海科學技術出版社, pp 1-10, 1980
25 Talanian, R.V., et al. Substrate specificities of caspase family protease, J. Biol. Chem., 272:9677-9682, 1997   DOI   ScienceOn
26 문구. 정병학, 김병주 편저. 암 동서의 결합치료. 권1, pp. 72-92, 93-98, 256-257, 1999
27 尹泳大. 扶正抗癌湯이 마우스의 체액성 및 세포성 면역반응과 탐식세포기능에 미치는 영향. 익산, 원광대학교 대학원, 1997
28 金完熙, 崔達永. 臟腑辨證論治. 서울, 成輔社, pp 140-142, 168-170, 281-284, 1985
29 KURT, J. ISSELBACHER 外. HARRISON'S PRINCIPLES OF INTERNAL MEDICINE Thirteenth Edition Volume 2, United States of America, Monotype Composition Company, pp 1814-1815, 1826-1840, 1817-1821, 1994
30 金定濟. 東醫臨床要覽. 서울, 書苑堂, pp 253-254, 1981
31 Green, D.R., Reed, J.C. Mitochondria and apoptosis. Science, 281:1309-1312, 1998   DOI
32 劑春安. 抗癌中草藥大辭典. 中國, 湖北科學技術出版社, pp 14-23, 33-35, 80-84, 115-119, 260-265, 294-297, 340-344, 367-371, 392-398, 398-401, 440-447, 538-543, 565-570, 704-708, 721-724, 817-820, 903-908, 1102-1104, 1994
33 Fadeel, B., Henter, J.I., Orrenius, S. Apoptosis required for maintenance of homeostasis: familial hemophagocytic lymphohitiocytosis caused by too little cell death Lakartidningen. 97:1395-1400, 1402, 2000
34 Searle, J., Kerr, J.F.R., Bishop, C.J. Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance, Pathol. Annu, 17:229-259, 1982
35 郞偉君. 抗癌中藥一千方. 北京, 中國醫藥技術出版社, pp 5-17, 1994
36 Mesner, P., Budihardjo, I., Kaufmann, S.H. Chemotherapy- induced apoptosis. Adv. Pharmacol. 41:461, 1997
37 서울대학교 의과대학. 腫瘍學. 서울대학교 출판부, pp 1-3, 23-24, 26-43, 137-143, 225-234, 1992
38 大韓病理學會 編. 病理學. 서울, 高文社, p 225, 1990
39 金柄住. 扶正抗癌湯의 抗腫瘍효과에 관한 실험적 硏究. 益山, 원광대학교 대학원, 1997
40 Enari, M., Talanian, R.V., Wong, W.W., Nagata, S. Sequential activation of ICE-like and CPP32-like protease during Fas-mediated apoptosis, Nature 380:723-726. 1996   DOI   ScienceOn
41 李家康. 中醫腫瘤防治大全. 中國, 科學技術文獻出版社, pp 10-47, 76-103, 142-150, 1994
42 공격덕, 이상욱, 한병훈, 서승연, 허만하, 박병채. 진행성 위암에 대한 5-FU, Adriamycin 및 Cisplatin(FAC) 병용화학요법의 치료효과. 대한암학회지 22: 144, 1990
43 Scott, H.K., William, C.E. Induction of apoptosis by cancer chemotherapy. Experimental Cell Research, 256:42-49, 2000   DOI   ScienceOn
44 Yang, J., Lui, X., Bhalla, K., Kim, C.N., Ibrado, A.M., Cai, J., Peng, T.I., Jones, D.P., Wang, X. Prevention of apoptosis by Bcl-2: realease of cytochrome c frome mitochondria blocked. Science, 275:1129-1132, 1997   DOI
45 余桂淸. 歷代中醫腫瘤案論選粹. 北京, 北京出版社, pp 1-2, 1988
46 Freisen, C., Herr, I., Krammer, P.H., Debatin, K.M. Invovement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in Leukemia cells. Nature Med. 2: 574-577, 1996   DOI   ScienceOn
47 Huang, S., Huang, C.F., Lee, T. Induction of mitosis- mediated apoptosis by sodicum arsenite in HeLa S3 cells. Biochem Pharmacol. 60:771-780. 2000   DOI   ScienceOn